Feed / RKDA

Arcadia Biosciences, Inc.

RKDA

Consumer Defensive · 0.43 -8.7% today

Isolated · not yet confirmedMarket checked 11 Sept, 15:45 GMT-4

Market read

Arcadia Biosciences, Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 17 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 5 directly disclosed connections are confirming.

Company-8.7% todayVolume comparison unavailable
Market group0 of 17 activeFinancial & Industrial Services · unavailable
Disclosed network0 of 5 confirmingNo filing-linked name is confirming now
What would change this read
  • RKDA's market-adjusted activity becomes unusual and at least one connected name confirms.

Invalidation: The isolated read changes if RKDA's group or a disclosed connection begins moving with it.

Watch this read

Research brief

The story so far

Consumer Defensive · Packaged Foods

No new filing conclusion is available. 0 of 17 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 5 directly disclosed connections are confirming.

Evidence that supports

No thresholded supportive filing evidence is available yet.

Evidence that challenges

No thresholded adverse filing evidence is available yet.

What would clarify the read
  • RKDA's market-adjusted activity becomes unusual and at least one connected name confirms.

Company research

Understand the business, not just the ticker

As of Sep 12, 2026
Business model and earnings drivers

Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.

Key research questions
  • Which operating variable is changing?
  • Is that change durable, cyclical or one-off?
  • What evidence would disprove the current interpretation?
Annual periods9
Price observations320
Usable filing statements50
Verified relationships5
Evidence supporting the case
  • Operating margin changed +20.8 percentage points in the latest annual period.
  • Net margin changed +91.4 percentage points in the latest annual period.
Evidence challenging the case
  • Latest annual revenue changed -3.7% year over year.
  • Product pipeline and R&D has repeated adverse evidence across 3 filings.
Questions before a position

No credible peer-relative valuation comparison is available yet.

Longer-term price context

Price as of Sep 11, 2026

0.43
6m-78.1%12m-88.8%24m
Annual trajectory

Reported annual revenue and per-share history. This is accounting history, not a forecast.

PeriodRevenueYoYDiluted EPSShare change
2021-12-31$6.8M-15.6%$-27.56
2022-12-31$7.4M+9.4%$-25.65+12.7%
2023-12-31$4.5M-40.0%$-11.29
2024-12-31$5.0M+13.3%$-5.17+10.2%
2025-12-31$4.9M-3.7%$-1.71+0.3%

What management says matters

Persistent and emerging business drivers

Product pipeline and R&Dnegative · 3 filings
Research and development expenses Research and development expenses decreased by $44,000, or 83%, in 2025 compared to 2024, reflecting our strategy to develop the Zola brand by leveraging our existing resources and minimizing new investment.
10-K · Mar 26, 2026
Customer concentrationmixed · 1 filings
Arcadia expects its quarterly operating results to fluctuate widely and unpredictably for the following reasons, among others: • its significant customer concentration; • the effectiveness of its marketing and advertising efforts; • the impact of seasonality…
10-K · Mar 26, 2026
Demand and volumemixed · 1 filings
Arcadia expects its quarterly operating results to fluctuate widely and unpredictably for the following reasons, among others: • its significant customer concentration; • the effectiveness of its marketing and advertising efforts; • the impact of seasonality…
10-K · Mar 26, 2026
Input and raw-material costspositive · 1 filings
Operating expenses (income) Cost of revenues Cost of revenues increased by $135,000, or 5%, in 2025 compared to 2024 driven by a 17% increase in Zola sales, which increased product costs and freight expenses.
10-K · Mar 26, 2026

Valuation discipline

Peer-relative valuation withheld

Jodie found no industry-matched filing peers suitable for a valuation comparison. It will not substitute broader financial-sector names.

Scenario scaffold

Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.

Price action

How the market is pricing the story

0.43-8.7% today

Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 11 Sept, 15:45 GMT-4; this is a coverage limitation, not a flat-price conclusion.

Developments

No sourced recent-development timeline yet

Jodie has not returned a relevant primary source or news item for RKDA. This is an evidence-coverage gap, not a conclusion that nothing material happened.

Business and financial condition

Reported financial figures are not available yet

Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.

Filing analysis

No comparable filing assessment is available yet

Jodie has not yet found a suitable current-versus-prior filing comparison for RKDA. This does not mean the latest filing was neutral or immaterial.

Business ecosystem

The relationships behind RKDA

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

CTVACorteva, Inc.partnerMar 26, 2026

On May 14, 2024, Arcadia sold its non-GMO Resistant Starch (“RS”) durum wheat trait to longtime partner Corteva Agriscience (“Corteva”) for total cash consideration of $4.0 million.

BIOXFiling-linked namepartnerMay 14, 2026

18 On March 28, 2025, Arcadia entered into an agreement with Bioceres Crop Solutions Corp.

Depended on by

ASTHAstrana Health, Inc.competitorMar 12, 2026

Our competitors include Conifer Health Solutions, InnovAccer, Arcadia, Lightbeam Health Solutions, and Lumeris.

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 2 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

RKDA is currently a Follower in the organic co-movement group Financial & Industrial Services. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for RKDA; it is not active in the latest market snapshot.

Context history

Theme membership history

No durable theme membership has been observed for this name yet.